Is the new variant of Corona - Omicron Mild?

Omicron is the new variant that is creating havoc these days worldwide. Remember, that omicron is a mildly infectious disease that is spreading. Let us know what WHO and AIIMS can tell us about omicron.

It may be noted that in November last year, a new variant of Corona, Omicron, was detected. The World Health Organization had declared this new variant of Corona as a Variant of Concern. Now, this variant has reached 128 countries of the world and its infection is increasing rapidly. In view of the Omicron infection in India, strict restrictions have been imposed in many states and it is believed that if the corona infection continues to grow like this, then the country may go into a state of lockdown again.

A vaccination campaign for children above 15 years of age has also been started in the country from January 3. Experts are constantly advising to get vaccines, wear masks and follow the rules of social distancing to prevent corona infection.

The AIIMS chief said that the symptoms of this disease are mild but people should not be careless towards it.

Regarding the Omicron variant in the country, AIIMS chief Dr. Randeep Guleria has said that people should not be afraid or panic about it. Dr. Guleria said that the Omicron variant is not more dangerous because only mild symptoms have been seen in the disease caused by it. But, people need to be careful. The AIIMS chief said that people should follow the Kovid-19 protocol, people should get the covid vaccine, and wear masks. Apart from this, follow social distancing and stay away from the crowd because even though the symptoms of this disease are mild, people should not be careless towards it. 

Let us inform you that Dr. Guleria had said some time ago that due to the statistics of vaccination in the country, the immunity among the people has increased a lot. Similarly, health facilities are also in better condition than before. The preparedness to combat the Kovid infection in the country is better and adequate beds and oxygen support are available in the covid centers and hospitals.

Omicron variant is not scary

Many things are being talked about about new variants of coronavirus and an atmosphere of fear is being created among the people. But, AIIMS Director Dr. Randeep Guleria has said that this new variant of coronavirus is not such that there is a need to panic. He said that the disease caused by the Omicron variant is showing very mild symptoms of infection. It does not have much of a bad effect on the lungs. The symptoms seen in infection include common cold and cough, fever, or body ache, which are very minor.

(Disclaimer: The content on this site is for informational purposes only, and should not be taken as professional medical advice. Always seek the guidance of your doctor or other health professionals for any questions you may have regarding your health or a medical condition.)

Tags : #omicronmild #coronavariant #WHO #smitakumar #medicircle #myhealth

Related Stories

01 Mar

India’s Pharma Revolution: Can New Regulatory Reforms Unleash a $42 Billion Industry?

The potential rewards are enormous a robust, efficient, and competitive pharmaceutical industry that not only fuels domestic growth but also serves as a reliable supplier of essential medicines to the world.

View
27 Feb

India’s Newborns Are Dying from Sepsis And No One Is Talking About It

Newborn sepsis is a complex problem that requires innovative solutions. More funding for research on rapid diagnostic tests, alternative treatments is essential to tackle this growing crisis.

View
26 Feb

The Corporate Invasion of Indian Hospitals: What It Means for You

The question remains: will India’s hospital sector continue on its current trajectory and become a global leader in healthcare, or will the challenges of cost, infrastructure, and regulatory hurdles slow down this remarkable journey.

View
24 Feb

The Great Indian Medical Education Paradox: More Seats, Fewer Students, Collapsing System

The NMC’s strategy to allow non-medical faculty and offer incentives for non-clinical PG courses may help in the short term, but a broader shift in how medical education is structured is necessary.

View
24 Feb

The Dark Side of India’s Pharma Boom: How Banned Drugs Found a New Market in West Africa

Stricter regulations, greater transparency, and proactive enforcement are the only ways to ensure that India’s “pharmacy of the world” reputation is built on trust and safety, not on scandals and cover-ups.

View
21 Feb

India vs. Trump’s Pharma Tariff: The Battle Over Affordable Medicine

Indian pharmaceutical companies may suffer short-term financial setbacks, but they hold the upper hand, because the U.S. needs Indian generics more than India needs the U.S. market.

View
19 Feb

Public Hospitals Go High-Tech: AIIMS Delhi Leads India’s Robotic Surgery Wave

AIIMS sets a precedent for other hospitals across India to follow. If robotic surgery becomes more widespread, the dream of world-class healthcare for all Indians may not be as distant as it once seemed.

View
19 Feb

Tata’s ₹500-Crore Gamble: Is Healthcare the New Playground for India’s Corporate Giants?

As India’s healthcare sector continues to evolve, corporate giants like Tata are not just participants but key drivers of change.

View
12 Feb

First in India: Dr. Anshumala Shukla-Kulkarni Becomes Asia’s First Certified Endometriosis Specialist

Delayed diagnosis remains one of the biggest challenges. More awareness campaigns, educational programs, and inclusion of endometriosis can help detect the condition early and improve treatment outcomes.

View
04 Feb

India’s Doctor Shortage: Will Increasing Medical Seats Solve the Crisis?

Expanding medical education must go hand-in-hand with long-term planning, ensuring that both general physicians and specialists are trained to serve in all parts of the country.

View

-Advertisements-




Trending Now

Medanta Rolls Out ‘Colon Tunnel on Wheels’ to Drive Awareness on Colorectal Cancer Prevention & Early DetectionApril 01, 2025
Zigly launches 2 pet hospitals, opens 4 new stores; expects ARR to more than double in 1-2 yearsApril 01, 2025
University of Leeds Announces International Masters Regional Scholarships for 2025April 01, 2025
Avantor Recognized with Two Prestigious Awards at Asia-Pacific Biopharma Excellence Awards 2025April 01, 2025
Foundation Stone Laid for Madhav Netralaya Eye Hospital & Research CentreApril 01, 2025
Doomscrolling at Midnight: How Indians Are Sacrificing Sleep for ScreensMarch 31, 2025
Essential Medicines Price Surge: Are Patients Paying the Price?March 31, 2025
Prioritize your health during the holy days of RamzanMarch 31, 2025
Tired of Stomach Cramps? These Simple Foods Can Heal Your GutMarch 31, 2025
Regional growth booming for startups in 2024 - QBO Innovation studyMarch 31, 2025
Is long-acting HIV treatment as good as taking daily pills?March 31, 2025
Right to safe abortion cannot be dislocated from human rightsMarch 28, 2025
Popeyes® Opens Third Store in Hyderabad at Inorbit MallMarch 28, 2025
Popeyes® Opens Third Store in Hyderabad at Inorbit MallMarch 28, 2025
10 New HIV Cases in 2 Months: Has Kerala’s Drug Problem Gone Too Far?March 28, 2025
Type 2 Diabetes Under Attack: The Unexpected Power of Wearable TechMarch 28, 2025
Research identifies causes of catastrophic floodingMarch 28, 2025
Why a Few Extra Inches Around Your Waist Could Cost You Your LifeMarch 28, 2025
Young IT Professional Answers Call To Be Stem Cell DonorMarch 28, 2025
5 Hidden Signs of Nutrient Deficiency You Shouldn’t IgnoreMarch 28, 2025